别名 电压门控钠离子通道NAV1.8、hPN3、Nav1.8 + [14] |
简介 Tetrodotoxin-resistant channel that mediates the voltage-dependent sodium ion permeability of excitable membranes. Assuming opened or closed conformations in response to the voltage difference across the membrane, the protein forms a sodium-selective channel through which sodium ions may pass in accordance with their electrochemical gradient. Plays a role in neuropathic pain mechanisms. |
作用机制 GR激动剂 [+1] |
在研机构 |
原研机构 |
非在研适应症- |
最高研发阶段批准上市 |
首次获批国家/地区 土耳其 |
首次获批日期1997-08-01 |
作用机制 COX抑制剂 [+2] |
非在研适应症- |
最高研发阶段批准上市 |
首次获批国家/地区 日本 |
首次获批日期1959-08-06 |
开始日期2024-09-22 |
申办/合作机构 |
开始日期2024-09-10 |
申办/合作机构- |
开始日期2024-09-01 |